Moderna Italy SRL vs. Arbutus Biopharma Corp
UPC_CFI_607/2025
Case Details
Case Number
UPC_CFI_607/2025
Patent Number
Filing Date
2025-07-08
Proceeding Type
Counter claim for revocation
Case Phase
Interim Phase
Case Decision Date
—
Court Division
The Hague (NL) Local Division
Parties & Representative
Claimants
Represented By
6 Representatives ListedRepresentative
Representative
Representative
Representative
Representative
Representative
Defendants
Represented By
6 Representatives ListedRepresentative
Representative
Representative
Representative
Representative
Representative
Court & Judges
Court / Division
The Hague (NL) Local Division
Judges
Edger Brinkman
Margot Kokke
Samuel Granata
Xavier Dorland-Galliot
Patents Involved
There is a single patent involved in this case.
| Application Number | Patent Number | External Links |
|---|---|---|
| - | EP4241767 |
Docket Entries
Exhibit FBD-T 46
2025-07-08
No Actions
Exhibit FBD-T 31
2025-07-08
No Actions
Exhibit FBD-T 59
2025-07-08
No Actions
Exhibit FBD-T 37
2025-07-08
No Actions
Exhibit FBD-T 22
2025-07-08
No Actions
Exhibit FBD-T 66
2025-07-08
No Actions
Exhibit FBD-T 44
2025-07-08
No Actions
Exhibit FBD-T 12
2025-07-08
No Actions
Exhibit FBD-T 54
2025-07-08
No Actions
Exhibit FBD-T 2
2025-07-08
No Actions
Exhibit FBD-T 7
2025-07-08
No Actions
Exhibit FBD-T 43
2025-07-08
No Actions
Exhibit FBD-T 9
2025-07-08
No Actions
Exhibit FBD-T 3
2025-07-08
No Actions
Exhibit FBD-T 64
2025-07-08
No Actions
Exhibit FBD-T 18
2025-07-08
No Actions
Exhibit FBD-T 39
2025-07-08
No Actions
Exhibit FBD-T 69
2025-07-08
No Actions
Exhibit FBD-T 38
2025-07-08
No Actions
Exhibit FBD-T 58
2025-07-08
No Actions
Exhibit FBD-T 34
2025-07-08
No Actions
Exhibit FBD-T 68
2025-07-08
No Actions
Exhibit FBD-T 47
2025-07-08
No Actions
Exhibit FBD-T 29
2025-07-08
No Actions
Exhibit FBD-T 41
2025-07-08
No Actions
Exhibit FBD-T 50
2025-07-08
No Actions
Exhibit FBD-T 21
2025-07-08
No Actions
Exhibit FBD-T 56
2025-07-08
No Actions
Exhibit FBD-T 27
2025-07-08
No Actions
Exhibit FBD-T 24
2025-07-08
No Actions
Exhibit FBD-T 6
2025-07-08
No Actions
Exhibit FBD-T 42
2025-07-08
No Actions
Exhibit FBD-T 26
2025-07-08
No Actions
Exhibit FBD-T 35
2025-07-08
No Actions
Exhibit FBD-T 15
2025-07-08
No Actions
Exhibit FBD-T 65
2025-07-08
No Actions
Exhibit FBD-T 48
2025-07-08
No Actions
Exhibit FBD-T 20
2025-07-08
No Actions
Exhibit FBD-T 40
2025-07-08
No Actions
Exhibit FBD-T 36
2025-07-08
No Actions
Exhibit FBD-T 62
2025-07-08
No Actions
Exhibit FBD-T 23
2025-07-08
No Actions
Exhibit FBD-T 10
2025-07-08
No Actions
Exhibit FBD-T 52
2025-07-08
No Actions
Exhibit FBD-T 51
2025-07-08
No Actions
Exhibit FBD-T 70
2025-07-08
No Actions
Exhibit FBD-T 32
2025-07-08
No Actions
Exhibit FBD-T 8
2025-07-08
No Actions
Exhibit FBD-T 19
2025-07-08
No Actions
Exhibit FBD-T 1
2025-07-08
No Actions
Exhibit FBD-T 49
2025-07-08
No Actions
Exhibit FBD-T 25
2025-07-08
No Actions
Exhibit FBD-T 33
2025-07-08
No Actions
Exhibit FBD-T 61
2025-07-08
No Actions
Exhibit FBD-T 67
2025-07-08
No Actions
Exhibit FBD-T 4
2025-07-08
No Actions
Exhibit FBD-T 16
2025-07-08
No Actions
Exhibit FBD-T 57
2025-07-08
No Actions
Exhibit FBD-T 60
2025-07-08
No Actions
Exhibit FBD-T 11
2025-07-08
No Actions
Exhibit FBD-T 28
2025-07-08
No Actions
Exhibit FBD-T 63
2025-07-08
No Actions
Exhibit FBD-T 53
2025-07-08
No Actions
Exhibit FBD-T 55
2025-07-08
No Actions
Exhibit FBD-T 30
2025-07-08
No Actions
Exhibit FBD-T 45
2025-07-08
No Actions
Exhibit FBD-T 17
2025-07-08
No Actions
EP 767 - Moderna Statement of Defence and Counterclaim for Revocation
2025-07-08
No Actions
Exhibit FBD-T 13
2025-07-08
No Actions
Exhibit FBD-T 14
2025-07-08
No Actions
Exhibit FBD-T 5
2025-07-08
No Actions
Formal-checks_Request-for-correction
2025-07-10
No Actions
Panel-Appointment
2025-07-17
No Actions
EPO-Request-for-case-pending
2025-07-17
No Actions
Acknowledgement-of-lodging
2025-07-17
No Actions
Formal-checks_Notification-of-positive-outcome
2025-07-17
No Actions
Exhibit FBD-T 70
2025-07-17
No Actions
Exhibit FBD-T 18
2025-07-17
No Actions
Exhibit FBD-T 27
2025-07-17
No Actions
Exhibit FBD-T 46
2025-07-17
No Actions
Exhibit FBD-T 60
2025-07-17
No Actions
Exhibit FBD-T 30
2025-07-17
No Actions
Exhibit FBD-T 6
2025-07-17
No Actions
Exhibit FBD-T 39
2025-07-17
No Actions
Exhibit FBD-T 11
2025-07-17
No Actions
Exhibit FBD-T 20
2025-07-17
No Actions
Exhibit FBD-T 7
2025-07-17
No Actions
Exhibit FBD-T 19
2025-07-17
No Actions
Exhibit FBD-T 44
2025-07-17
No Actions
Exhibit FBD-T 28
2025-07-17
No Actions
Exhibit FBD-T 21
2025-07-17
No Actions
2025-07-08_-_UPC2_EP767_Moderna_Statement_of_Defence_and_Counterclaim_for_Revocation
2025-07-17
No Actions
Exhibit FBD-T 25
2025-07-17
No Actions
Exhibit FBD-T 37
2025-07-17
No Actions
Exhibit FBD-T 10
2025-07-17
No Actions
Exhibit FBD-T 48
2025-07-17
No Actions
Exhibit FBD-T 57
2025-07-17
No Actions
Exhibit FBD-T 64
2025-07-17
No Actions
Exhibit FBD-T 65
2025-07-17
No Actions
Exhibit FBD-T 24
2025-07-17
No Actions
Exhibit FBD-T 17
2025-07-17
No Actions
Exhibit FBD-T 42
2025-07-17
No Actions
Exhibit FBD-T 51
2025-07-17
No Actions
Exhibit FBD-T 29
2025-07-17
No Actions
Exhibit FBD-T 52
2025-07-17
No Actions
Exhibit FBD-T 67
2025-07-17
No Actions
Exhibit FBD-T 16
2025-07-17
No Actions
Exhibit FBD-T 5
2025-07-17
No Actions
Exhibit FBD-T 38
2025-07-17
No Actions
Exhibit FBD-T 26
2025-07-17
No Actions
Exhibit FBD-T 3
2025-07-17
No Actions
Exhibit FBD-T 61
2025-07-17
No Actions
Exhibit FBD-T 2
2025-07-17
No Actions
Exhibit FBD-T 15
2025-07-17
No Actions
Exhibit FBD-T 62
2025-07-17
No Actions
Exhibit FBD-T 12
2025-07-17
No Actions
Exhibit FBD-T 4
2025-07-17
No Actions
Exhibit FBD-T 40
2025-07-17
No Actions
Exhibit FBD-T 53
2025-07-17
No Actions
Exhibit FBD-T 35
2025-07-17
No Actions
Exhibit FBD-T 68
2025-07-17
No Actions
Exhibit FBD-T 34
2025-07-17
No Actions
Exhibit FBD-T 50
2025-07-17
No Actions
Exhibit FBD-T 58
2025-07-17
No Actions
Exhibit FBD-T 33
2025-07-17
No Actions
Exhibit FBD-T 8
2025-07-17
No Actions
Exhibit FBD-T 69
2025-07-17
No Actions
Exhibit FBD-T 41
2025-07-17
No Actions
Exhibit FBD-T 45
2025-07-17
No Actions
Exhibit FBD-T 36
2025-07-17
No Actions
Exhibit FBD-T 32
2025-07-17
No Actions
Exhibit FBD-T 56
2025-07-17
No Actions
Exhibit FBD-T 1
2025-07-17
No Actions
Exhibit FBD-T 47
2025-07-17
No Actions
Exhibit FBD-T 31
2025-07-17
No Actions
Exhibit FBD-T 55
2025-07-17
No Actions
Exhibit FBD-T 59
2025-07-17
No Actions
Exhibit FBD-T 49
2025-07-17
No Actions
Exhibit FBD-T 66
2025-07-17
No Actions
Exhibit FBD-T 13
2025-07-17
No Actions
Exhibit FBD-T 54
2025-07-17
No Actions
Exhibit FBD-T 43
2025-07-17
No Actions
25-07-17_-_Moderna_vs_Genevant_Arbutus_-_EP767_-_Formal_response_to_request_for_amendments_-_CC_318331_2025
2025-07-17
No Actions
Exhibit FBD-T 23
2025-07-17
No Actions
Exhibit FBD-T 14
2025-07-17
No Actions
Exhibit FBD-T 22
2025-07-17
No Actions
Exhibit FBD-T 9
2025-07-17
No Actions
Exhibit FBD-T 63
2025-07-17
No Actions
Document from EPO
2025-07-21
No Actions
Document from EPO
2025-07-22
No Actions
Document from EPO
2025-07-22
No Actions
Document from EPO
2025-07-22
No Actions
Document from EPO
2025-07-22
No Actions
EPO_Communication_check_Outcome
2025-07-23
No Actions
EPO_Communication_check_Outcome
2025-07-23
No Actions
EPO_Communication_check_Outcome
2025-07-23
No Actions
EPO_Communication_check_Outcome
2025-07-25
No Actions
Acknowledgement of access to case
2025-07-29
No Actions
Notification Of Service
2025-07-29
No Actions
Exhibit A095 - Bajaj 2007 - Effect of the headgroup variation on the gene transfer properties of cholesterol based catio
2025-09-10
No Actions
Exhibit A091 - EP 767 Claim requests (clean version)
2025-09-10
No Actions
Exhibit A102 - US 61/242,761 - FBD-T 63 P3
2025-09-10
No Actions
Exhibit A112 - Coelho 2013 - Safety and efficacy of RNAi therapy for transthyretin amyloidosis
2025-09-10
No Actions
Exhibit A106 - US 61/222,464 - FBD-T 67 P1
2025-09-10
No Actions
Exhibit A096 - Song 1997 - Characterization of Cationic liposome-mediated Transfer In Vivo by Intravenous Administration
2025-09-10
No Actions
Exhibit A097 - Sabnis 2018 - A novel amino lipid series for mRNA delivery: improved endosomal escape and sustained pharm
2025-09-10
No Actions
Exhibit A118 - Moderna IT webpage
2025-09-10
No Actions
Exhibit A098 - Prof. Dr. Ir. De Geest declaration (including annexes)
2025-09-10
No Actions
Exhibit A116 - Moderna ES supply invoicing EU states
2025-09-10
No Actions
Exhibit A101 - US 61/234,045 - FBD-T 63 P2
2025-09-10
No Actions
Exhibit A114 - Maier 2013 - Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery o
2025-09-10
No Actions
Exhibit A115 - Arbutus Genevant CLA 2018 SEC
2025-09-10
No Actions
Exhibit A111 - Schlich 2021 - Cytosolic delivery of nucleic acids The case of ionizable lipid
2025-09-10
No Actions
Exhibit A109 - Semple 2010 - Rational design of cationic lipids for siRNA delivery
2025-09-10
No Actions
Exhibit A092 - EP 767 Claim requests (tracked changes version)
2025-09-10
No Actions
Exhibit A113 - Lv 2006 - Toxicity of cationic lipids and cationic polymers in gene delivery
2025-09-10
No Actions
Exhibit A093 - Heyes 2005 - Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids
2025-09-10
No Actions
Exhibit A108 - US 61/231,579 - FBD-T 62 P2
2025-09-10
No Actions
Exhibit A103 - US 61/251,999 - FBD-T 63 P4
2025-09-10
No Actions
Exhibit A100 - US 61/175,777 - FBD-T 63 P1
2025-09-10
No Actions
Exhibit A107 - US 61/159,788 - FBD-T 62 P1
2025-09-10
No Actions
Reply to SoD + Defence to CC + App to Amend
2025-09-10
No Actions
Exhibit A094 - Jeffs 2005 - A Scalable Extrusion-Free Method for Efficient Liposomal Encapsulation of Plasmid DNA
2025-09-10
No Actions
Exhibit A099 - Register extract of FBD-T 66
2025-09-10
No Actions
Exhibit A105 - US 61/222/469 - FBD-T 65 P1
2025-09-10
No Actions
Exhibit A110 - Semple 2010 - Rational design of cationic lipids for siRNA delivery - supplementary information
2025-09-10
No Actions
Exhibit A117 - Belgium trade register registrations for Moderna Biotech Spain, Moderna Switzerland and Moderna Netherlan
2025-09-10
No Actions
Exhibit A104 - US 61/258,848 - FBD-T 63 P5
2025-09-10
No Actions
Formal-checks_Notification-of-positive-outcome
2025-09-10
No Actions
Acknowledgement-of-lodging
2025-09-10
No Actions
Exhibit A096 - Song 1997 - Characterization of Cationic liposome-mediated Transfer In Vivo by Intravenous Administration
2025-09-10
No Actions
Exhibit A091 - EP 767 Claim requests (clean version)
2025-09-10
No Actions
Exhibit A103 - US 61-251.999 - FBD-T 63 P4
2025-09-10
No Actions
Exhibit A092 - EP 767 Claim requests (tracked changes version)
2025-09-10
No Actions
Exhibit A102 - US 61-242.761 - FBD-T 63 P3
2025-09-10
No Actions
Reply to SoD + Defence to CC + App to Amend
2025-09-10
No Actions
Exhibit A094 - Jeffs 2005 - A Scalable, Extrusion-Free Method for Efficient Liposomal Encapsulation of Plasmid DNA
2025-09-10
No Actions
Exhibit A104 - US 61-258.848 - FBD-T 63 P5
2025-09-10
No Actions
Exhibit A100 - US 61-175.777 - FBD-T 63 P1
2025-09-10
No Actions
Exhibit A098 - Prof. Dr. Ir. De Geest declaration (including annexes)
2025-09-10
No Actions
Exhibit A097 - Sabnis 2018 - A novel amino lipid series for mRNA delivery - improved endosomal escape and sustained phar
2025-09-10
No Actions
Exhibit A095 - Bajaj 2007 - Effect of the headgroup variation on the gene transfer properties of cholesterol based catio
2025-09-10
No Actions
Exhibit A109 - Semple 2010 - Rational design of cationic lipids for siRNA delivery
2025-09-10
No Actions
Exhibit A107 - US 61-159.788 - FBD-T 62 P1
2025-09-10
No Actions
Exhibit A101 - US 61-234.045 - FBD-T 63 P2
2025-09-10
No Actions
Exhibit A112 - Coelho 2013 - Safety and efficacy of RNAi therapy for transthyretin amyloidosis
2025-09-10
No Actions
Exhibit A099 - Register extract of FBD-T 66
2025-09-10
No Actions
Exhibit A105 - US 61-222.469 - FBD-T 65 P1
2025-09-10
No Actions
Exhibit A113 - Lv 2006 - Toxicity of cationic lipids and cationic polymers in gene delivery
2025-09-10
No Actions
Exhibit A106 - US 61-222.464 - FBD-T 67 P1
2025-09-10
No Actions
Exhibit A110 - Semple 2010 - Rational design of cationic lipids for siRNA delivery - supplementary information
2025-09-10
No Actions
Exhibit A115 - Arbutus - Genevant Cross-License Agreement 2018 (SEC version)
2025-09-10
No Actions
Exhibit A093 - Heyes 2005 - Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids
2025-09-10
No Actions
Exhibit A116 - Moderna Biotech Spain documentation of Spikevax supply and invoicing to EU states
2025-09-10
No Actions
Exhibit A118 - Moderna Italy webpage
2025-09-10
No Actions
Exhibit A114 - Maier 2013 - Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery o
2025-09-10
No Actions
Exhibit A111 - Schlich 2021 - Cytosolic delivery of nucleic acids The case of ionizable lipid
2025-09-10
No Actions
Exhibit A117 - Belgium trade register registrations for Moderna Biotech Spain - Moderna Switzerland and Moderna Netherla
2025-09-10
No Actions
Exhibit A108 - US 61-231.579 - FBD-T 62 P2
2025-09-10
No Actions
Acknowledgement-of-lodging
2025-09-11
No Actions
Formal-checks_Notification-of-positive-outcome
2025-09-11
No Actions
Panel-Appointment
2025-09-17
No Actions
Cover sheet
2025-11-10
No Actions
Exhibit document Claimant
2025-11-10
No Actions
Exhibit document Claimant
2025-11-10
No Actions
Exhibit document Claimant
2025-11-10
No Actions
Exhibit document Claimant
2025-11-10
No Actions
Exhibit document Claimant
2025-11-10
No Actions
Exhibit document Claimant
2025-11-10
No Actions
Exhibit document Claimant
2025-11-10
No Actions
Exhibit document Claimant
2025-11-10
No Actions
Counterclaim reply
2025-11-10
No Actions
Application to Amend Patent Defence
2025-11-10
No Actions
Receipt
2025-11-10
No Actions
Cover sheet
2025-12-10
No Actions
Exhibit document Defendant
2025-12-10
No Actions
Exhibit document Defendant
2025-12-10
No Actions
Exhibit document Defendant
2025-12-10
No Actions
Counterclaim rejoinder
2025-12-10
No Actions
Receipt
2025-12-10
No Actions
action.communication.general
2025-12-11
No Actions
Cover sheet
2025-12-15
No Actions
Further pleadings
2025-12-15
No Actions
Receipt
2025-12-15
No Actions
Cover sheet
2025-12-16
No Actions
Exhibit document Defendant
2025-12-16
No Actions
Exhibit document Defendant
2025-12-16
No Actions
Receipt
2025-12-16
No Actions
action.communication.general
2025-12-16
No Actions
Cover sheet
2025-12-18
No Actions
Further pleadings
2025-12-18
No Actions
Receipt
2025-12-18
No Actions
action.issueOrder.order
2025-12-23
No Actions
Order
2025-12-23
No Actions
Receipt
2026-01-12
No Actions
Cover sheet
2026-01-12
No Actions
Statement of rejoinder
2026-01-12
No Actions
Exhibit document Defendant
2026-01-12
No Actions
Exhibit document Defendant
2026-01-12
No Actions
Exhibit document Defendant
2026-01-12
No Actions
action.phaseChange.interimPhaseOpen
2026-01-14
No Actions
action.phaseChange.writtenPhaseClose
2026-01-14
No Actions
Receipt
2026-01-21
No Actions
Cover sheet
2026-01-21
No Actions
Other document Defendant
2026-01-21
No Actions
Receipt
2026-01-21
No Actions
Cover sheet
2026-01-21
No Actions
Other document Defendant
2026-01-21
No Actions
action.issueOrder.order
2026-02-12
No Actions
Order
2026-02-12
Receipt
2026-02-19
No Actions
Cover sheet
2026-02-19
No Actions
Exhibit Claimant
2026-02-19
No Actions
Exhibit Claimant
2026-02-19
No Actions
Receipt
2026-02-26
No Actions
Cover sheet
2026-02-26
No Actions
Fee
2026-02-26
No Actions
Application document Claimant
2026-02-26
No Actions
Receipt
2026-02-27
No Actions
Cover sheet
2026-02-27
No Actions
Document Claimant
2026-02-27
No Actions
action.communication.general
2026-02-27
No Actions
Receipt
2026-03-04
No Actions
Cover sheet
2026-03-04
No Actions
Application document Defendant
2026-03-04
No Actions
Hearing recording reference document
2026-03-09
No Actions
EN pdf 1
2026-08-25